Hi, what are you looking for?
Israel-based Kadimastem, a biotechnology company developing cell therapies for the treatment of severe debilitating diseases announced positive interim results from the Phase 2...
– The company recently reported positive results in its first pre-clinical trial for the treatment of ALS. – Israeli biotechnology company Kadimastem announces today...
Israel’s Kadimastem has been having much success with its revolutionary technology that uses microscopic stem cells to protect or repair brain function. Pharmaceutical giant Merck...
– Israeli biotechnology company Kadimastem (TASE: KDST) has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases...
– Yossi Ben-Yossef, CEO and Founder of Kadimastem German global pharmaceutical company Merck Serono, and Israeli Kadimastem (TASE:KDST) , a developer of human pluripotent stem cell-based drug...
In the March 8, 2015 edition of Israel’s good news, the highlights include: · Innovative Israeli chemotherapy can treat ovarian and brain...
Israel’s Good News for Aug 31st 2014 ISRAEL’S MEDICAL ACHIEVEMENTS A foolproof method for diagnosing ADHD. Scientists at Tel Aviv University, Sheba Medical Center...
– In the 29th Dec 2013 edition of Israel’s good news: ECONOMY & BUSINESS Starting a business in Tel Aviv? Free consulting, marketing, legal...
– Why ? Because : “Israel took third place in the “Innovation” category in the latest Global Competitiveness Ranking published by the World Economic Forum....
– Orscan will presumably try to raise a few tens of millions of shekels at a company value of NIS 70-80 million, after money....